Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neo-adjuvant FOLFOXIRI and Chemoradiotherapy for High Risk ("Ugly") Locally Advanced Rectal Cancer

NCT04838496 is registered in ClinicalTrials.gov with Catharina Ziekenhuis Eindhoven as lead sponsor.

NCT NCT04838496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04838496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neo-adjuvant FOLFOXIRI and Chemoradiotherapy for High Risk ("Ugly") Locally Advanced Rectal Cancer
Lead sponsor
Catharina Ziekenhuis Eindhoven
Phase
Phase 2
Overall status
Unknown status
Start date
June 1, 2021
Completion date
June 1, 2026
Enrollment
128 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer